Login
Toggle navigation
Videos
Categories
Trending
Sander Geophysics receives the 202 Employer Award.|Luise Sander is co-presidents of Sander Geophysics
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Luise Sander is co-presidents of Sander Geophysics
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Exploring Derrida: Philosophy and Controversy|Mark Dooley,Professor,University College Dublin
00:10:00
Paying Yourself First: What It Means and How to Do It | Ian draws , Founder , Open World Financial Life Planning.
00:10:00
Thesis Gold: Advancing High-Grade Gold Exploration in North Central British Columbia
00:10:00
Good global citizenship takes on a distinct meaning in light of its many pro bono efforts|David I. Gottlieb,Partner,Cleary Gottlieb Steen & Hamilton LLP
00:10:00
Private Equity in Sri Lanka: Opportunities for Growth and Investment Insights from Zephyr Management's Thomas Barry
00:10:00
Get to know Erica Yount of Modera Wealth Management, LLC
00:10:00
"Comprehensive Overview of BBVA Mercados Privados 2022, FCR - A Multi-Strategy Private Equity Fund by BBVA Asset Management"
00:10:00
Understanding Roth Conversions: Benefits, Drawbacks, and Timing | Ben Smith - FOUNDER & FINANCIAL PLANNER of Cove Financial Planning, LLC
00:10:00
Empowering Small Farmers: Sri Lankan Agriculture Reaching Global Markets|Sarath Ganegoda,Executive Director,Hayleys Fibre PLC
00:10:00
CEO Review: Blue Bird Vision Diesel Bus on PIT Grand Tour | Phil Horlock - CEO of Blue Bird Corporation
00:10:00
Abiding commitment to public service that dates back for decades|Harrison J Buzz Frahn,Partner,Simpson Thacher
00:10:00
John Howard on Australia's Role in the Iraq War and U.S. Alliance|John Howard